Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × Metformin × 1 year × Clear all

Sponsor

Conditions

Polycystic Ovary Syndrome 18 Glioblastoma 6 Prostatic Neoplasms 4 Obesity 3 Neoplasm Metastasis 3 Leukoplakia, Oral 3 Erythroplasia 3 Endometrial Neoplasms 3 Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Mouth Neoplasms 2 Metabolic Syndrome 2 Medulloblastoma 2 Insulin Resistance 2 Infertility 2 Carcinoma, Intraductal, Noninfiltrating 2 Weight Loss 1 Weight Gain 1 Urothelial Cancer 1 Thyroid Diseases 1 TP53 Y220C Mutation 1 Smoldering Multiple Myeloma 1 Sarcoma 1 Rectal Neoplasms 1 Prostate Cancer Recurrent 1 Prediabetic State 1 Posterior Fossa Ependymal Tumor 1 Pleural Effusion, Malignant 1 Pathologic Complete Response 1

Interventions

Trastuzumab 13 pertuzumab 8 Docetaxel 6 tucatinib 5 pyrotinib 4 Capecitabine 4 Paclitaxel 3 Carboplatin 2 Ado-Trastuzumab Emtansine 2 trastuzumab deruxtecan 1 pegfilgrastim 1 neratinib 1 exemestane 1 dalpiciclib 1 Leuprolide 1 Isovaleryl-CoA Dehydrogenase 1 Injections 1 Goserelin 1 Fulvestrant 1 Fluorodeoxyglucose F18 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡